Bank of New York Mellon’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
+124,365
New +$592K ﹤0.01% 3543
2025
Q2
Sell
-85,917
Closed -$111K 4285
2025
Q1
$111K Hold
85,917
﹤0.01% 3990
2024
Q4
$215K Buy
85,917
+45
+0.1% +$160 ﹤0.01% 3929
2024
Q3
$349K Buy
85,872
+38,763
+82% +$145K ﹤0.01% 3687
2024
Q2
$165K Buy
47,109
+6,412
+16% +$26.1K ﹤0.01% 3981
2024
Q1
$105K Sell
40,697
-710
-2% -$2.52K ﹤0.01% 4029
2023
Q4
$193K Buy
41,407
+7,434
+22% +$37.2K ﹤0.01% 3964
2023
Q3
$224K Buy
+33,973
New +$227K ﹤0.01% 3921

Other funds holding ZURA

Bank of New York Mellon's ZURA Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Zura Bio (ZURA) in Q2 2026: 124,365 shares worth $734K. The stake represents ﹤0.01% of the portfolio and ranks #3543 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ZURA as recently as Q1 2025.

Bank of New York Mellon first reported a position in ZURA in Q3 2023 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Bank of New York Mellon held 124,365 shares of Zura Bio worth $734K as of Q2 2026.
  • Zura Bio was a new Bank of New York Mellon position in Q2 2026.
  • Zura Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3543 holding.
  • Bank of New York Mellon first reported a position in Zura Bio in Q3 2023 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.